Late Breaking Abstract - An interim analysis of a phase 2 trial evaluating oral nalbuphine extended release for treating chronic cough in idiopathic pulmonary fibrosis

T. Maher (Los Angeles, United States), W. Forbes (New Haven, United States), E. Bortey (New Haven, United States), T. Sciascia (New Haven, United States)

Source: International Congress 2022 – What is hot in interstitial lung diseases

Session: What is hot in interstitial lung diseases
Session type: Oral Presentation
Number: 1395

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Maher (Los Angeles, United States), W. Forbes (New Haven, United States), E. Bortey (New Haven, United States), T. Sciascia (New Haven, United States). Late Breaking Abstract - An interim analysis of a phase 2 trial evaluating oral nalbuphine extended release for treating chronic cough in idiopathic pulmonary fibrosis. 1395

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.